Milestone Pharmaceuticals (MIST) EBIT (QoQ) (2018 - 2022)
Milestone Pharmaceuticals (MIST) EBIT (QoQ) (2018 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.51 Bn | 78.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.74 Bn | 60.56 Bn | 1.37 Bn |
| 4 | Moderna | 59.39 Bn | 54.26 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.15 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.78 Bn | 28.47 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.39 Bn | - |
| 10 | Milestone Pharmaceuticals | 43.11 Mn | -128.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 10.57% |
| Dec 31, 2021 | -18.53% |
| Sep 30, 2021 | -2,104.63% |
| Jun 30, 2021 | 105.65% |
| Mar 31, 2021 | -43.73% |
| Dec 31, 2020 | 27.50% |
| Sep 30, 2020 | 7.78% |
| Jun 30, 2020 | 21.80% |
| Mar 31, 2020 | 11.30% |
| Dec 31, 2019 | -37.65% |
| Sep 30, 2019 | 4.25% |
| Jun 30, 2019 | -31.14% |
| Mar 31, 2019 | -8.14% |
| Dec 31, 2018 | -74.71% |
| Sep 30, 2018 | -57.37% |
| Jun 30, 2018 | 13.61% |